While dysregulation of RUNX3 expression has been reported in various cancer cells and the effect and cause of the dysregulation were extensively studied,10 the involvement of RUNX3 in tumor stroma was documented only in a single publication in which RUNX3 was included in the stromal gene set associated with good clinical outcomes of breast carcinomas.16 This evidence concerns the gene RUNX3 and cancer.